SPY303.53+4.45 1.49%
DIA255.77+5.52 2.21%
IXIC9,412.36+72.14 0.77%

Morgan Stanley Maintains Equal-Weight on Portola Pharmaceuticals, Raises Price Target to $18

Morgan Stanley maintains Portola Pharmaceuticals (NASDAQ:PTLA) with a Equal-Weight and raises the price target from $14 to $18.

Benzinga · 05/08/2020 12:58

Morgan Stanley maintains Portola Pharmaceuticals (NASDAQ:PTLA) with a Equal-Weight and raises the price target from $14 to $18.